The project is part of a $1.7 million National Institutes of Health grant to study the use of AI for in-home care. The project will enroll 50 adults from Mass General’s Frontotemporal Disorders Unit, according to a Feb. 27 Sonde news release.
Participants will record audio samples from cognitive assessments. The voice recording will then be analyzed for signs of cognitive impairment.
“As the population of older adults continues to grow, there is a critical need for remote monitoring technologies that can detect cognitive impairment early and accurately,” Deepak Ganesan, PhD, director of the MassAITC, said. “By supporting a study that combines Sonde Health’s vocal biomarker technology and Massachusetts General Hospital’s expertise in clinical dementia research, we believe we’re one step closer to developing the tools and resources needed to elevate aging-in-place care models.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
